Development

Lilly reports growth in senior GLP-1 use

development2026-09-22biotech

Claim

The newsletter reports Lilly's figure of 700,000 seniors using GLP-1s since July.

Reported metric: 700,000; since July

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Indexed from the September 22 newsletter. Linked-source claims have not been independently verified.

Knowledge graphopen in browser →

Reported in
Actor
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.